| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |